$LFMD News
Last published 15h ago
- 15h agoLFMDLifeMD, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 1.01 Item 2.02 Item 2.03 Item 3.02 Item 7.01 Item 9.01
- 6d agoLFMDLFMDPLifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026GlobeNewswireNEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today...
- 6d agoLFMDLFMDPLifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026GlobeNewswireNEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care and pharmacy services, today announced that the Company has rescheduled its third quarter 2026
- 1w agoLFMDLFMDPLifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwideGlobeNewswireNEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today announced an arrangement with Eli Lilly and Company (Lilly) that enables LifeMD's
- 3w agoLFMDLFMDPLifeMD to Report Third Quarter 2026 Financial Results on November 9GlobeNewswireNEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care and pharmacy services, announces that it will report financial results for the three and nine months
- 1mo agoTLFMDAT&T Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMDPR NewswireThrough an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a complimentary LifeMD membership, a $228 annual...
- 3mo agoLFMDLFMDPUPDATE - LifeMD Reports Second Quarter 2026 ResultsGlobeNewswireUPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of
- 3mo agoLFMDLFMDPLifeMD Reports Second Quarter 2026 ResultsGlobeNewswireSecond quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, improving approximately 21% sequentially.Approximately
- 3mo agoLFMDLFMDPLifeMD to Report Second Quarter 2026 Financial Results on August 5GlobeNewswireNEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30,
- 4mo agoLFMDLFMDPLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockGlobeNewswireNEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the
- 4mo agoLFMDLFMDPLifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) InjectionGlobeNewswireLandmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July
- 5mo agoLFMDLFMDPLifeMD Appoints Umesh Sripad as Chief Technology OfficerGlobeNewswireNEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Umesh Sripad as Chief Technology Officer (CTO), effective
- 6mo agoLFMDLFMDPLifeMD to Participate in Upcoming Investor ConferencesGlobeNewswireNEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences.
- 6mo agoLFMDLFMDPLifeMD Reports First Quarter 2026 ResultsGlobeNewswireFirst quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company's guidance.Gross margin increased approximately 420 basis points to 88%, versus the
- 6mo agoLFMDLFMDPLifeMD to Report First Quarter 2026 Financial Results on May 6GlobeNewswireNEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2026,
- 7mo agoLFMDLFMDPLifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight ManagementGlobeNewswireNEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo™ (orforglipron) to eligible patients
- 7mo agoLFMDLFMDPLifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription ProgramGlobeNewswireNEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the launch of Novo Nordisk's new Wegovy® (semaglutide) subscription
- 7mo agoLFMDLFMDPLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockGlobeNewswireNEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the
- 8mo agoLFMDLFMDPLifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership TeamGlobeNewswireNEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Atul Kavthekar as Chief Financial Officer, effective
- 8mo agoLFMDLFMDPLifeMD Reports Fourth Quarter and Full Year 2025 ResultsGlobeNewswireFull year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.Successfully launched oral
- 8mo agoLFMDLFMDPLifeMD to Participate in Two Investor Conferences During MarchGlobeNewswireNEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences
- 8mo agoLFMDLFMDPLifeMD to Report Fourth Quarter 2025 Financial Results on March 9GlobeNewswireNEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December
- 9mo agoLFMDKuehn Law Encourages Investors of LifeMD, Inc. to Contact Law FirmGlobeNewswireNEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of LifeMD, Inc. (NASDAQ:LFMD) breached their fiduciary duties to
- 10mo agoLFMDLFMDPLifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.GlobeNewswireNEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured revolving credit facility
- 10mo agoLFMDLFMDPLifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® PillGlobeNewswireNEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care and pharmacy services, today announced it is now offering Novo Nordisk's Wegovy® (semaglutide)
- 10mo agoLFMDLFMDPLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockGlobeNewswireNEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced that its Board of Directors has authorized a cash
- 11mo agoLFMDLFMDPLifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026GlobeNewswireNEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on both the 2025 Deloitte
- 12mo agoLFMDLFMDPLifeMD Reports Third Quarter 2025 ResultsGlobeNewswireTotal revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million.Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.Paid
- 12mo agoLFMDLFMDPLifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo NordiskGlobeNewswireNEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services and pharmacy, today announced a new, lower cash-pay price for GLP-1 medications, Wegovy®
- 1y agoLFMDLFMDPLifeMD to Participate in the BTIG Digital Health ForumGlobeNewswireNEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services and pharmacy, today announced its participation in the virtual BTIG Digital Health Forum on
- 1y agoLFMDLFMDPLifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17GlobeNewswireNEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third quarter 2025 earnings
- 1y agoLFMDLFMDPLifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy PlatformGlobeNewswireNEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual healthcare services and pharmacy, today announced the sale of its majority ownership interest in WorkSimpli Software
- 1y agoLFMDINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMDPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or the "Company")...
- 1y agoLFMDLifeMD, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 27, 2025 to Discuss Your Rights - LFMDPR NewswireThe Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the...
- 1y agoLFMDLFMDPLifeMD to Report Third Quarter 2025 Financial Results on November 6GlobeNewswireNEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September
- 1y agoLFMDLFMDPLifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health ProgramGlobeNewswireNEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the appointment of Tara Scott, MD, widely known as "The Hormone Guru," as
- 1y agoLFMDInvestors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights – LFMDGlobeNewswireNEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ:LFMD). Shareholders who purchased shares of LFMD during the class period listed are
- 1y agoLFMDShareholders of LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMDPR NewswireThe Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the...
- 1y agoLFMDThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMDPR NewswireThe Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the...
- 1y agoLFMDLFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMDGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options If you purchased or acquired
- 1y agoLFMDINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMDGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses in LifeMD between May
- 1y agoLFMDLFMDPLifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo NordiskGlobeNewswireNEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides
- 1y agoLFMDInvestors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMDPR NewswireThe Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the...
- 1y agoLFMDLFMDPLifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities ConferenceGlobeNewswireNEW YORK, Sept.
- 1y agoLFMDLFMDPLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockGlobeNewswireNEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the
- 1y agoLFMDShareholders of LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMDPR NewswireThe Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the...
- 1y agoLFMDSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMDGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses
- 1y agoLFMDLFMDPLifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at ScaleGlobeNewswireNEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the expansion of its state-of-the-art affiliated pharmacy to include
- 1y agoLFMDInvestors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMDPR NewswireThe Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the...
- 1y agoLFMDINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMDPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or the "Company")...